IRTC

iRhythm Holdings, Inc. provides an end-to-end cardiac monitoring service utilizing its Zio® ECG monitors and advanced AI technology. The company generates revenue by offering continuous, long-term cardiac monitoring solutions that deliver clinically actionable reports to healthcare providers. Its primary customers include cardiologists, electrophysiologists, and primary care physicians, as well as patients requiring cardiac monitoring. iRhythm operates primarily in the United States, with its technology also available in select international markets.